ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus (CANVAS-R)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01989754
Recruitment Status : Completed
First Posted : November 21, 2013
Last Update Posted : February 22, 2018
Sponsor:
Collaborator:
The George Institute for Global Health, Australia
Information provided by (Responsible Party):
Janssen Research & Development, LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 23, 2017
  Actual Study Completion Date : February 23, 2017
  Certification/Extension First Submitted : February 20, 2018
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):